resveratrol has been researched along with ADPKD in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, HC; Chua, KH; Lim, SK; Mahendran, R; Ong, KC | 1 |
| Chen, M; Chen, S; Gu, J; Hu, H; Jing, Y; Mei, C; Mei, S; Qi, N; Wu, M; Wüthrich, RP; Xu, D; Yang, B; Yang, M; Yao, Q | 1 |
| Moradi, H; Vaziri, ND | 1 |
1 review(s) available for resveratrol and ADPKD
| Article | Year |
|---|---|
Natural-derived compounds and their mechanisms in potential autosomal dominant polycystic kidney disease (ADPKD) treatment.
Topics: Antioxidants; Chalcones; Curcumin; Diterpenes; Diterpenes, Kaurane; Emodin; Epoxy Compounds; Estrogen Antagonists; Flavanones; Humans; Hypoglycemic Agents; Metformin; Phenanthrenes; Plant Extracts; Polycystic Kidney, Autosomal Dominant; Protein Kinase Inhibitors; Quercetin; Resveratrol | 2021 |
2 other study(ies) available for resveratrol and ADPKD
| Article | Year |
|---|---|
Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Chemokine CCL2; Disease Progression; Dogs; Humans; Inflammation; Madin Darby Canine Kidney Cells; Male; NF-kappa B; Polycystic Kidney Diseases; Polycystic Kidney, Autosomal Dominant; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes; Tumor Necrosis Factor-alpha; Zebrafish | 2016 |
Effect of resveratrol on progression of polycystic kidney disease: a case of cautious optimism.
Topics: Disease Progression; Humans; Kidney; Polycystic Kidney Diseases; Polycystic Kidney, Autosomal Dominant; Resveratrol; Stilbenes | 2016 |